| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |